BiotechTube
Home/Mogling Bio/Anne Eldrup
AE

Anne Eldrup

Chief Development Officer (CDO)

Mogling Bio

Therapeutic Areas

AgingMusculoskeletalImmunologyNeurologyHematology

Mogling Bio Pipeline

DrugIndicationPhase
Cdc42 Inhibition Platform (CASIN)Multiple age-related diseases (e.g., Osteoporosis, Immunosenescence, Neurodegeneration)Pre-clinical

Leadership Team at Mogling Bio

JR
Jürgen Reeß
Co-founder
YZ
Yi Zheng
Co-founder, Cdc42/CASIN Expert
HG
Hartmut Geiger
Co-founder, Stem Cell Aging and Rejuvenation Expert
TT
Tim Tracy
Chief Scientific Officer (CSO)
NH
Norbert Hauel
Medicinal Chemistry Expert
View full Mogling Bio profile